ArticleAntibiotics (Basel, Switzerland)2024

Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAP.

Milo Gatti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.